Employees with laboratory-confirmed influenza have more lost work time-including absences and reduced productivity while at work-compared to those with other types of acute respiratory illness (ARI), reports a study in the December Journal of Occupational and Environmental Medicine.
"Compared to non-influenza ARI, workers with influenza lose an additional half-day of work due to absenteeism/presenteeism over the week following symptom onset," write Jeffrey J. VanWormer, PhD, and colleagues of Marshfield Clinic Research Institute, Marshfield, Wisc.
The study included data on 1,278 employed adults who had ARI over four influenza seasons, from 2012-13 to 2015-16. As part of a vaccine effectiveness study, all underwent laboratory tests to confirm the presence or absence of influenza virus infection.
Testing confirmed influenza in 470 employees. Productivity loss over seven to 17 days after initial symptoms was compared for workers with influenza versus non-influenza ARI. Productivity loss included not only absenteeism but also presenteeism: days the employee was at work but less productive due to illness.
Employees with confirmed influenza lost an average 69 percent of expected work hours, compared to 58 percent for those with non-influenza ARI. "A typical full-time employee could expect to lose about 3½ of their 5 work days in a given week…due to absenteeism and presenteeism from an influenza infection," the researchers write. Productivity loss was similar for workers infected with different influenza virus strains.
While previous studies have suggested high productivity losses due to influenza, few studies have included laboratory testing to confirm influenza. Dr. VanWormer and colleagues conclude: "Future research should explore specific financial returns on employer investments in initiatives and policies designed to help their employees prevent seasonal influenza transmission and infection, and minimize the economic impact of ARI."
Source: Wolters Kluwer Health: Lippincott Williams and Wilkins
Pseudomonas aeruginosa: Infection Risks, Challenges, and Breakthroughs for Health Care Professionals
September 19th 2024Pseudomonas aeruginosa, a highly virulent pathogen, poses significant risks to immunocompromised patients, presenting challenges in treatment due to its antibiotic resistance and environmental persistence.
Advancing Infection Prevention With Diagnostic Innovation: Insights From Alesia McKeown, PhD
September 17th 2024Alesia McKeown, PhD, discusses the pivotal role of cutting-edge diagnostic technologies in enhancing infection prevention, especially in high-risk health care environments, during an interview with Infection Control Today.
The Role of Accurate Testing in Preventing Respiratory Illnesses: Insights from Dr. Aparna Ahuja
September 17th 2024On Get Ready for Flu Day, Dr. Aparna Ahuja discusses the importance of accurate respiratory illness testing, the risks of self-diagnosis, and the role of infection prevention personnel in public health education.
How Cleaning Medical Equipment Directly Affects Patient Safety and Equipment Longevity
September 16th 2024Hospital-associated infections affect over 1 million US patients annually. Proper medical equipment cleaning and sterilization significantly reduce infection risks, improving patient outcomes and safety.
Top 3 Secrets to Effective Infection Prevention and Control Through Strategic MDRO Surveillance
September 13th 2024Sean Brown’s 2024 Disease Prevention Summit presentation emphasized leveraging technology, prioritizing high-risk patients, and environmental surveillance to enhance infection prevention and control strategies.